Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting

Exact Sciences logo Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests Exact Sciences (NASDAQ:EXAS) held a special meeting of stockholders on February 20, 2026, to vote on proposals related to its previously announced merger agreement with Abbott Laboratories. Kevin Conroy, chairman of Exact Sciences’ board of directors, presided over the virtual meeting. James Herriott, the company’s senior vice president, general counsel, and secretary, served as secretary of the meeting. Conroy said me ...